Harvard Study Reveals Antidepressants’ Weight Gain Rankings

Weight gain can have adverse effects for those suffering from anxiety and depression, potentially affecting medication adherence and overall treatment success.
Harvard Study Reveals Antidepressants’ Weight Gain Rankings
T.Den_Team/Shutterstock
|Updated:
0:00
A new study released on Monday by Harvard Medical School and Harvard Pilgrim Health Care Institute reveals the varying impacts of commonly prescribed antidepressants on body weight. Published in the Annals of Internal Medicine, these findings provide essential insights for clinicians and patients concerned about the side effects of antidepressant medications.

Key Findings of the Study

The Harvard-led research examined the impact of eight commonly prescribed first-line antidepressants on weight gain over two years. Analyzing electronic health records of 183,118 adults from eight U.S. health systems who began taking the antidepressants between 2010 and 2019, the study included sertraline, citalopram, escitalopram, fluoxetine, paroxetine, bupropion, duloxetine, and venlafaxine.

Researchers identified small but notable differences in weight changes among the medications. Bupropion (Wellbutrin) users experienced a slight average weight loss over time compared to sertraline (Zoloft) users, the reference group.

Sheramy Tsai
Sheramy Tsai
Author
Sheramy Tsai, BSN, RN, is a seasoned nurse with a decade-long writing career. An alum of Middlebury College and Johns Hopkins, Tsai combines her writing and nursing expertise to deliver impactful content. Living in Vermont, she balances her professional life with sustainable living and raising three children.
Related Topics